Reaction
Oligomenorrhoea reporting signals
As of the last recalculation, Oligomenorrhoea appears in 2,150 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL (PRR 40.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etonogestrel | 183 | 40.5 | 40.6 |
| Etonogestrel And Ethinyl Estradiol | 78 | 35.3 | 35.4 |
| Tranexamic Acid | 11 | 12.0 | 12.0 |
| Drospirenone And Ethinyl Estradiol | 50 | 11.2 | 11.2 |
| Copper | 48 | 11.0 | 11.0 |
| Levonorgestrel | 194 | 10.2 | 10.2 |
| Cariprazine | 5 | 5.2 | 5.2 |
| Medroxyprogesterone Acetate | 26 | 5.1 | 5.1 |
| Leuprolide Acetate | 28 | 3.5 | 3.5 |
| Fremanezumab-Vfrm | 4 | 3.4 | 3.4 |
| Orlistat | 6 | 2.2 | 2.2 |
| Erenumab-Aooe | 10 | 1.8 | 1.8 |
| Galcanezumab-Gnlm | 5 | 1.5 | 1.5 |
| Tirzepatide | 17 | 1.0 | 1.0 |